Steven Van Laecke

9PUBLICATIONS
23CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cross-sectional analysisInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 13, 2025
Lymphocyte Phenotypes and Protein-Bound Uremic Toxins as Determinants of Clinical Outcomes in Hemodialysis Patients.

Theodoros Tourountzis, Georgios Lioulios, Stamatia Stai

|Apr 10, 2025
Primary FSGS is not associated with worse kidney outcome compared with other FSGS subtypes.

Dries Deleersnijder, Evert Cleenders, Maarten Coemans

|Nov 24, 2022
Immunosenescence: an unexplored role in glomerulonephritis.

Steven Van Laecke, Karel Van Damme, Amélie Dendooven

|Dec 05, 2020
5-Year outcomes of the prospective and randomized CISTCERT study comparing steroid withdrawal to replacement of cyclosporine with everolimus in de novo kidney transplant patients.

Lissa Pipeleers, Daniel Abramowicz, Nilufer Broeders

|Apr 04, 2018
Cardiovascular disease after transplantation: an emerging role of the immune system.

Steven Van Laecke, Thomas Malfait, Eva Schepers

Pageof 2

Frequent Collaborators

2 joint publications

Amélie Dendooven

1 joint publications

Lissa Pipeleers

1 joint publications

Dries Deleersnijder

1 joint publications

Björn K Meijers